| abstract |
A method to ameliorate inflammatory effects by providing an anti-platelet derived growth factor (anti-PDGF) agent. In one embodiment the agent is imatinib. In another embodiment the agent is dasatinib. The method reduces the undesirable effects of post-surgical scarring, such as restenosis, because of the anti-inflammatory effect of the anti-PDGF agent. The method may be used in patients undergoing any type of surgery, such as cardiac surgery, ocular surgery, vascular surgery, etc. |